Skip to main content
logo
Chordia Therapeutics Inc. (TYO:190A)
Japan flag Japan · Delayed Price · Currency is JPY
78.00
0.00 (0.00%)
Aug 6, 2026, 1:21 PM JST

Chordia Therapeutics Cash Flow Statement

Millions JPY. Fiscal year is Sep - Aug.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Aug '25 Aug '24 Aug '23
Net Income
-1,786-1,827223.34
Depreciation & Amortization
2.74.096.04
Asset Writedown & Restructuring Costs
13.78--
Other Operating Activities
128.24-224.68229.54
Change in Other Net Operating Assets
-195.77110.4684.81
Operating Cash Flow
-1,837-1,937543.73
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Aug '25 Aug '24 Aug '23
Capital Expenditures
-5.33-0.54-0.35
Sale (Purchase) of Intangibles
---0.38
Other Investing Activities
--10.421.07
Investing Cash Flow
-5.33-10.960.35

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Aug '25 Aug '24 Aug '23
Issuance of Common Stock
61.581,479-
Financing Cash Flow
61.581,479-

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Aug '25 Aug '24 Aug '23
Miscellaneous Cash Flow Adjustments
-0-00
Net Cash Flow
-1,781-469.41544.08

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Aug '25 Aug '24 Aug '23
Free Cash Flow
-1,842-1,938543.38
Free Cash Flow Growth
---
Free Cash Flow Margin
--21.73%
Free Cash Flow Per Share
-26.85-32.999.63
Levered Free Cash Flow
-1,192-1,243-
Unlevered Free Cash Flow
-1,192-1,243-

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Aug '25 Aug '24 Aug '23
Cash Income Tax Paid
2.422.422.42
Change in Working Capital
-195.77110.4684.81